Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers April 23, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - April 23, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 88     Next >>     Go To Page:

4/13/17 - BioMarin Announces Kuvan (sapropterin dihydrochloride) Patent Challenge Settlement
BioMarin Pharmaceutical Inc., today announced that it has entered into a settlement agreement with Par Pharmaceutical that resolves patent litigation in the United States related to BioMarin's Kuvan 100 mg oral tablets and powder for oral solution in 100 mg packets. Under the terms of the settlement, BioMarin will grant Par a non-exclusive lic
4/13/17 - FREDS INC - 10-K - : Management's Discussion and Analysis of Financial Condition and Results of Operations
The following information contains references to years 2016, 2015 and 2014, which represent fiscal years ended January 28, 2017, January 30, 2016 and January 31, 2015. Executive Overview As of January 28, 2017, Fred's and its subsidiaries operate 628 pharmacy and general merchandise stores and three specialty pharmacy-only locations along with 16..
4/13/17 - Lake Forest drugmaker Akorn confirms it's in takeover talks with German pharma giant [Chicago Tribune]
April 12 Shares of Lake Forest-headquartered Akorn Pharmaceuticals closed up more than 9 percent Monday, following news Friday that a German health care company is considering buying the generic drugmaker. Akorn spokeswoman Stephanie Carrington declined to comment further on the discussions Monday. In Illinois, in addition to its headquarters, Ak
4/12/17 - Innovus Pharmaceuticals Receives Patent for Its Sensum+ Product in Morocco
Innovus Pharmaceuticals, Inc., an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men s and women s health and vitality and respiratory diseases, today announced that i
4/11/17 - Lake Forest drugmaker Akorn confirms it's in takeover talks with German pharma giant [Chicago Tribune]
April 11 Shares of Lake Forest- based Akorn Pharmaceuticals closed up more than 9 percent Monday, following news Friday that a German health care company is considering buying the generic drugmaker. Akorn spokeswoman Stephanie Carrington declined to comment further on the discussions Monday. In Illinois, in addition to its headquarters, Akorn ope
4/10/17 - BUYINS.NET: BUYINS.NET: CTBI, SWK, BWA, CNC, MSEX, CRL Expected To Be Up Before Next Earnings Releases
Community Trust Bancorp Inc., Stanley Black& Decker Inc., BorgWarner Inc., Centene Corporation, Middlesex Water Company, Charles River Laboratories International Inc. are all expected to be Up Before their earnings are released Monday. Symbol Company# of Reports Quarter Release Date. CTBI Community Trust Bancorp Inc. April Earnings Q1 04/10/2017.
4/10/17 - BUYINS.NET: CTBI, SWK, BWA, CNC, MSEX, CRL Expected To Be Up Before Next Earnings Releases
April 10, 2017 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly...
4/10/17 - Egalet Corporation Announces Changes to Board of Directors
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced that Jean-Francois Formela, MD has resigned from Egalet's board of directors. "We're thankful to Jean-Francois for his exceptional dedication and...
4/10/17 - German drugmaker Stada agrees takeover [EuroNews]
A lengthy takeover process has ended with German drugmaker Stada agreeing to be bought by investment groups Bain Capital and Cinven. Founded in 1895 in Dresden as a pharmacists cooperative, Stada is one of the last independent generic drug makers in Europe and also makes over-the-counter medicines. Cinven and Bain said they would like to buy mor
4/10/17 - IVD Market Healthy as Procedure Volume Exceeds 21 Billion
Kalorama said that in vitro diagnostic procedures are exceeding 21 billion globally in its latest report. "Growth in procedures means growth in reagents and instruments sold in general terms," said Bruce Carlson, Publisher of Kalorama Information. Except for Alere, which specializes in products for point-of-care markets, all of the other industr
4/10/17 - Lake Forest drugmaker Akorn confirms it's in takeover talks with German pharma giant [Chicago Tribune]
April 10 Shares of Lake Forest-headquartered Akorn Pharmaceuticals were up more than 8 percent Monday morning, following news late last week that a German health care company is considering buying the generic drugmaker. Akorn spokeswoman Stephanie Carrington declined to comment further on the discussions Monday. In Illinois, in addition to its...
4/7/17 - Blog Coverage Valeant's Bausch + Lomb Receives FDA Clearance for Vision Enhancement System
LONDON, UK/ ACCESSWIRE/ April 7, 2017/ Active Wall St. blog coverage looks at the headline from Valeant Pharmaceuticals International, Inc.. On April 06, 2017, Bausch+ Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, announced that it has received 510 clearance from the US Food and Drug Administration for the Stellaris Elit
4/7/17 - M Pharmaceutical Inc. Enhances USA Market Profile and Trading with DTC Eligibility Approval on OTC
M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or M Pharma) announces today that it has been made eligible for book-entry delivery and depository services of The Depository Trust Company (the "DTC") to facilitate electronic settlement and transfer of its common shares on the US stock exchange OTC (otcmarkets.com, sym
4/7/17 - Sleeping Aids Market by Market Share, Size Analysis and Forecast 2023
Albany, NY 04/07/2017 Some of the key players in the sleeping aids market are Merck& Co., Sanofi, Pfizer, Koninklijke Philips N.V., Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Care Fusion Corporation, SleepMed, Inc, Cadwell, Teva Pharmaceutical Industries Ltd, Natus Medical Incorporated, Compumedics Limited. and DeVilbiss Heal
4/6/17 - Bausch + Lomb Receives 510(k) Clearance From FDA For Stellaris Elite? Next-Generation Phacoemulsification Platform
Valeant Pharmaceuticals International, Inc.' s wholly owned subsidiary, Bausch+ Lomb, today announced it has received 510 clearance from the U.S. Food and Drug Administration for the Stellaris Elite? Vision Enhancement System, the company's next generation phacoemulsification cataract platform. "We are pleased to continue to deliver on our pla
4/6/17 - Imprimis Pharmaceuticals Acquires Exclusive License to Patented Ophthalmic Formulation for Dry Eye Disease
Imprimis Pharmaceuticals, Inc., an ophthalmology-focused pharmaceutical company, announced today that it has entered into an licensing agreement for the exclusive worldwide rights to Klarity, an innovative and patented ophthalmic topical solution and gel technology for patients with dry eye disease. The technology was developed by Richard L. Lind
4/6/17 - Sen. Alexander: Scott Gottlieb has Impressive Qualifications and is the Right Person to Lead FDA and its 'Vital Mission'
Scott Gottlieb has "impressive qualifications from nearly every perspective" and is the right person to lead the Food and Drug Administration and its "vital mission" for patients. "The Food and Drug Administration has always been important," Alexander said, "but there's never been a more important time to capitalize on the significant funding Cong
4/6/17 - Sen. Alexander: Scott Gottlieb Has Impressive Qualifications, Is Right Person to Lead FDA and Its 'Vital Mission'
Scott Gottlieb has "impressive qualifications from nearly every perspective" and is the right person to lead the Food and Drug Administration and its "vital mission" for patients. "The Food and Drug Administration has always been important," Alexander said, "but there's never been a more important time to capitalize on the significant funding Cong
4/6/17 - Sen. Murray Questions President Trump's Nominee to Lead FDA About Potential Conflicts of Interest, Commitment to Providing Independent Leadership
Scott Gottlieb, nominee for Commissioner of the Food and Drug Administration, about his commitment to "ensure independent, science-based decision-making at the FDA" at a hearing to consider his nomination. "In the limited time we have had to review your professional history and background, I have grown increasingly concerned about whether you can
4/5/17 - ACETO Subsidiary, Rising Pharmaceuticals, to Launch Capecitabine Tablets, 150 & 500 mg
Release date- 28032017- PORT WASHINGTON, N.Y- ACETO Corporation, an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced the U.S. launch& commercial shipments of Capecitabine Tablets, 150& 500 mg, an AB rated, generic versio
4/5/17 - ACETO Subsidiary, Rising Pharmaceuticals, to Launch Zileuton Extended Release Tablets, 600 mg
Release date- 30032017- PORT WASHINGTON, N.Y- ACETO Corporation, an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, has launched Zileuton.
4/5/17 - Alexander: Scott Gottlieb Has Impressive Qualifications and Is the Right Person to Lead FDA
FDA affects nearly every single American and regulates about a quarter of all consumer spending in the United States over $4 trillion annually. "The Food and Drug Administration has always been important, but there's never been a more important time to capitalize on the significant funding Congress has given to medical researchand to realize t
4/5/17 - Alexander: Scott Gottlieb Has Impressive Qualifications and Is the Right Person to Lead FDA and Its "Vital Mission"
Scott Gottlieb has "impressive qualifications from nearly every perspective" and is the right person to lead the Food and Drug Administration and its "vital mission" for patients. "The Food and Drug Administration has always been important," Alexander said, "but there's never been a more important time to capitalize on the significant funding Cong
4/5/17 - Innovus Pharma Announces Receipt of Notification to Commercialize Zestra Glide in the European Union
Innovus Pharmaceuticals, Inc., an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men s and women s health and vitality and respiratory diseases, announced today that i
4/5/17 - Murray Questions President Trump's Nominee to Lead FDA About Potential Conflicts of Interest, Commitment to Providing Independent Leadership
Scott Gottlieb, nominee for Commissioner of the Food and Drug Administration, about his commitment to "ensure independent, science-based decision-making at the FDA" at a hearing to consider his nomination. "In the limited time we have had to review your professional history and background, I have grown increasingly concerned about whether you can
Articles(s): 1 - 25 of 88     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415